There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Background.
Respiratory viruses cause significant morbidity and hospitalization among children.
Recent advances in diagnostics have improved the ability to identify viral pathogens,
avoiding prolonged hospitalization and unnecessary antibiotic use. A molecular diagnostic
test was recently FDA approved (eSensor XT-8 with GenMark Dx).
Methods.
The standard of care to identify respiratory viral pathogens at our large pediatric
referral facility utilizes Direct Fluorescent Antibody (DFA), with viral culture on
DFA-negative specimens. GenMark probe testing was added to standard-of-care testing
for a total of 300 samples from inpatients during the 2012-13 respiratory season.
200 samples negative by DFA/culture and 100 positive by either DFA or viral culture
were used. Clinical data were collected. Length of stay was only calculated for those
≤ 21 days (n= 268), to exclude hospitalizations unlikely related to viral illness.
Results.
The eSensor RVP identified viral nucleic acids in 74.1% of samples, compared to 22.5%
from standard of care, thus tripling the diagnostic yield. Results by virus are listed
in the table. There was no association with longer hospitalization or higher acuity
among subjects with multiple viruses detected, or with influenza or RSV alone. Longer
length of stay and higher acuity was only associated with Coronavirus. OC43 was the
most common coronavirus identified (71%) and these associations remained significant.
Younger subjects were more likely to have RSV, HRV, and > 1 virus.
Subject Characteristics by Virus
Virus
N
Age (years) mean
Length of Stay (days) mean
p-value
Higher Acuity
p-value
Influenza A
6
3.8
5.8
0.7
1.4%
0.4
Influenza B
11
3.1
3.8
0.3
4.2%
0.8
RSV
26
1.7
5.9
0.3
8.3%
0.3
PIV
10
3.3
3.9
0.3
2.8%
0.4
hMPV
25
2.2
4.6
0.5
11.1%
0.9
HRV
42
1.9
4.3
0.2
18.1%
0.9
ADV
7
4.1
2.7
0.1
2.8%
0.9
Corona
34
3.4
7.3
0.004
25.0%
0.004
OC43
24
3.5
7.4
0.011
18.1%
0.012
> 1 virus detected
72
1.9
5.2
0.9
26.4%
0.4
Conclusion.
The improved sensitivity of the eSensor RVP identifies many more infections than
current standard of care. Coronavirus, especially OC43, could potentially represent
a more virulent pathogen, associated with both prolonged hospitalization and higher
acuity. Detecting > 1 virus in a hospitalized child is not predictive of higher acuity
illness or longer hospitalization.
Disclosures.
D. W. Kimberlin, GSK: Grant Investigator, served as study site for clinical trials
conducted by GSK (all monies went to university), Grant recipient; Gilead: Grant Investigator,
served as study site for clinical trials conducted by Gilead (all monies went to my
university). Grant recipient M. N. Prichard, GenMark: Investigator, Mark Prichard
received research funds from GenMark to defray costs associated with the study. and
Research support